Financials · CNMD

CONMED Corporation (CNMD) financials

For the twelve months ended Sep 30, 2026, CONMED Corporation reported $1.37B of revenue and $73.43M of net income.

Revenue, TTM
$1.37B
Revenue growth, YoY
+1.6%
Net income, TTM
$73.43M
Net income growth, YoY
+14.6%
Net margin
5.4%
Cash
$47.97M
Total debt
$635.76M
P/E
20.03
P/S
1.07
Market cap
$1.47B
Annual revenue$1.37B
FY2016FY2025
Annual net income$47.05M
FY2016FY2025
Annual free cash flow$150.88M
FY2016FY2025

CNMD revenue and earnings growth

CNMD revenueQ3 2026$335.56M

Quarter YoY
-0.7%
QoQ
-2.3%
FY YoY
+5.2%
5Y CAGR
+9.8%
10Y CAGR
+6.7%

CNMD revenue was $335.56M in fiscal Q3 2026 (ended Sep 30, 2026), down 0.7% from a year earlier and down 2.3% from the prior quarter. For the full fiscal 2025 it was $1.37B, up 5.2% from fiscal 2024. Compound annual growth was +9.8% over 5 years and +6.7% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

CNMD net incomeQ3 2026$19.80M

Quarter YoY
+592.4%
QoQ
-14.2%
FY YoY
-64.5%
5Y CAGR
+37.7%
10Y CAGR
+4.4%

CNMD net income was $19.80M in fiscal Q3 2026 (ended Sep 30, 2026), up 592.4% from a year earlier and down 14.2% from the prior quarter. For the full fiscal 2025 it was $47.05M, down 64.5% from fiscal 2024. Compound annual growth was +37.7% over 5 years and +4.4% over 10 years.

CNMD EPSQ3 2026$0.66

Quarter YoY
+633.3%
QoQ
-14.3%
FY YoY
-64.5%
5Y CAGR
+36.4%
10Y CAGR
+3.3%

CNMD diluted EPS was $0.66 in fiscal Q3 2026 (ended Sep 30, 2026), up 633.3% from a year earlier and down 14.3% from the prior quarter. For the full fiscal 2025 it was $1.51, down 64.5% from fiscal 2024. Compound annual growth was +36.4% over 5 years and +3.3% over 10 years.

CNMD free cash flowQ3 2026$46.73M

Quarter YoY
-3.7%
FY YoY
-2.0%
5Y CAGR
+24.0%
10Y CAGR
+15.4%

CNMD free cash flow was $46.73M in fiscal Q3 2026 (ended Sep 30, 2026), down 3.7% from a year earlier. For the full fiscal 2025 it was $150.88M, down 2.0% from fiscal 2024. Compound annual growth was +24.0% over 5 years and +15.4% over 10 years. It rose in 6 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue$1.37B$1.31B$1.24B$1.05B$1.01B$862.46M$955.10M$859.63M$796.39M$763.52M
Cost of revenue$624.25M$573.98M$568.50M$474.23M$442.60M$402.16M$430.38M$390.52M$365.35M$355.19M
Gross profit$750.48M$733.03M$676.25M$571.25M$568.04M$460.30M$524.72M$469.11M$431.04M$408.33M
Research and development$55.88M$54.43M$52.60M$47.15M$43.56M$40.47M$45.46M$42.19M$32.31M$32.25M
Selling, general and admin$591.97M$478.28M$503.04M$454.04M$414.75M$373.82M$400.14M$355.62M$351.80M$338.40M
Operating income$102.62M$200.33M$120.60M$70.05M$109.72M$46.01M$79.11M$71.31M$46.94M$37.68M
Interest expense$31.09M$37.30M$39.77M$28.91M$35.48M$44.05M$42.70M$20.65M$18.20M$15.36M
Pre-tax income$71.12M$163.03M$80.83M-$70.86M$73.11M$1.60M$31.23M$50.65M$28.73M$19.38M
Income tax$24.06M$30.61M$16.37M$9.72M$10.56M-$7.91M$2.60M$9.80M-$26.75M$4.71M
Net income$47.05M$132.42M$64.46M-$80.58M$62.54M$9.52M$28.62M$40.85M$55.49M$14.66M
EPS, basic$1.52$4.29$2.10-$2.68$2.14$0.33$1.01$1.45$1.99$0.53
EPS, diluted$1.51$4.25$2.04-$2.68$1.94$0.32$0.97$1.41$1.97$0.52
Diluted shares31.1M31.1M31.5M30.0M32.2M29.5M29.5M28.9M28.2M28.0M

Balance sheet

Balance sheet
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Cash and equivalents$40.82M$24.46M$24.30M$28.94M$20.85M$27.36M$25.86M$17.51M$32.62M$27.43M
Receivables$247.83M$237.73M$242.28M$191.34M$183.88M$177.15M$189.10M$181.55M$167.04M$148.24M
Inventory$355.54M$346.72M$318.32M$332.32M$231.64M$194.87M$164.62M$154.60M$141.44M$135.87M
Current assets$672.86M$640.01M$615.65M$581.23M$460.12M$416.65M$397.36M$374.35M$356.78M$330.51M
Goodwill$807.01M$805.36M$806.84M$815.43M$617.53M$618.44M$618.04M$400.44M$401.95M$397.66M
Total assets$2.33B$2.31B$2.30B$2.30B$1.77B$1.75B$1.78B$1.37B$1.36B$1.33B
Current liabilities$315.04M$278.13M$310.73M$296.55M$196.65M$190.20M$188.09M$160.94M$150.00M$113.95M
Short-term debt-------$18.34M$14.70M$10.20M
Long-term debt$834.23M$905.07M$973.14M$985.08M$672.41M$735.22M$755.21M$438.56M$471.74M$488.29M
Total debt$834.23M$905.07M$973.14M$985.08M$672.41M$735.22M$755.21M$456.90M$486.44M$498.49M
Total liabilities$1.29B$1.34B$1.47B$1.55B$980.58M$1.04B$1.06B$706.87M$726.53M$748.41M
Shareholders' equity$1.03B$962.68M$834.22M$745.54M$785.43M$709.04M$710.47M$662.27M$631.43M$580.58M

Cash flow

Cash flow
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Operating cash flow$170.69M$166.97M$125.35M$33.37M$111.77M$64.53M$95.13M$74.70M$65.57M$39.88M
Capital expenditures$19.81M$13.08M$19.03M$21.79M$14.87M$13.01M$20.07M$16.51M$12.84M$14.75M
Free cash flow$150.88M$153.88M$106.32M$11.58M$96.90M$51.52M$75.07M$58.19M$52.72M$25.13M
Investing cash flow-$20.96M-$13.08M-$20.03M-$249.53M-$14.87M-$13.64M-$387.66M-$16.51M-$29.05M-$266.02M
Financing cash flow-$135.82M-$151.00M-$110.43M$225.00M-$101.55M-$52.06M$300.88M-$72.27M-$34.88M$182.54M
Dividends paid$24.75M$24.65M$24.50M$23.96M$23.26M$22.82M$22.60M$22.44M$22.31M$22.21M
Share repurchases---------$0
Stock-based compensation$28.32M$25.56M$24.26M$21.73M$16.34M$13.11M$11.78M$10.04M$8.47M$8.38M

Key ratios

Key ratios
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue growth, YoY5.2%5.0%19.1%3.4%17.2%-9.7%11.1%7.9%4.3%6.2%
Net income growth, YoY-64.5%105.4%--557.2%-66.7%-29.9%-26.4%278.4%-51.9%
EPS growth, YoY-64.5%108.3%--506.3%-67.0%-31.2%-28.4%278.8%-52.3%
Gross margin54.6%56.1%54.3%54.6%56.2%53.4%54.9%54.6%54.1%53.5%
Operating margin7.5%15.3%9.7%6.7%10.9%5.3%8.3%8.3%5.9%4.9%
Net margin3.4%10.1%5.2%-7.7%6.2%1.1%3.0%4.8%7.0%1.9%
Free cash flow margin11.0%11.8%8.5%1.1%9.6%6.0%7.9%6.8%6.6%3.3%
Return on equity4.6%13.8%7.7%-10.8%8.0%1.3%4.0%6.2%8.8%2.5%
Return on assets2.0%5.7%2.8%-3.5%3.5%0.5%1.6%3.0%4.1%1.1%
Current ratio2.142.301.981.962.342.192.112.332.382.90
Debt to equity0.810.941.171.320.861.041.060.690.770.86

Source: XBRL data CONMED Corporation files with the SEC, latest filing dated Oct 28, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CNMD peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
CNMD$1.37B+1.6%$73.43M5.4%$1.47B
MDT$37.54B+9.8%$5.24B14.0%$131.60B
LIVN$1.51B+11.7%$196.06M13.0%$5.09B
ITGR$1.83B-0.3%$103.70M5.7%$4.31B
AXGN$266.93M+24.3%-$31.92M-12.0%$3.31B
TMDX$727.65M+28.5%$144.45M19.9%$3.20B
CBLL$108.72M+31.3%-$73.88M-68.0%$1.03B
INMD$370.50M-6.2%$93.83M25.3%$755.9M
CV$13.92M+6.4%-$29.25M-210.1%$346.9M

CNMD FAQ

7 questions
  • What is CNMD revenue?
    CONMED Corporation (CNMD) reported $1.37B of revenue for the twelve months ended Sep 30, 2026. That is up 1.6% from the year before. Revenue for fiscal 2025 was $1.37B.
  • Is CNMD profitable?
    Yes. CONMED Corporation earned $73.43M in net income for the twelve months ended Sep 30, 2026, a net margin of 5.4%.
  • How much cash and debt does CNMD have?
    CONMED Corporation reported $47.97M in cash and cash equivalents and $635.76M of debt on its most recent balance sheet in SEC filings.
  • How fast is CNMD revenue growing?
    CONMED Corporation's revenue changed +5.2% in fiscal 2025, to $1.37B. Its compound annual growth rate was +9.8% over 5 years and +6.7% over 10 years.
  • What is CNMD gross margin?
    CONMED Corporation's gross profit was $788.34M on $1.37B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 57.6%.
  • When did CNMD last report financial results?
    The latest statements here come from CONMED Corporation's 10-Q filed on Oct 28, 2026, covering the period ended Sep 30, 2026.
  • Where does this CNMD financial data come from?
    Quantisnow builds these statements from the structured XBRL data CONMED Corporation files with the SEC. It is provided for information only and is not investment advice.